Literature DB >> 20223233

SAMe prevents the induction of the immunoproteasome and preserves the 26S proteasome in the DDC-induced MDB mouse model.

Fawzia Bardag-Gorce1, Joan Oliva, Jun Li, Barbara A French, Samuel W French.   

Abstract

Mallory-Denk bodies (MDBs) form in the liver of alcoholic patients. This occurs because of the accumulation and aggregation of ubiquitinated cytokeratins, which hypothetically is due to the ubiquitin-proteasome pathway's (UPP) failure to degrade the cytokeratins. The experimental model of MDB formation was used in which MDBs were induced by refeeding DDC to drug-primed mice. The gene expression and protein levels of LMP2, LMP7 and MECL-1, the catalytic subunits in the immunoproteasome, as well as FAT10, were increased in the liver cells forming MDBs but not in the intervening normal hepatocytes. Chymotrypsin-like activity of the UPP was decreased by DDC refeeding, indicating that a switch from the UPP to the immunoproteasome had occurred at the expense of the 26S proteasome. The failure of the UPP to digest cytokeratins would explain MDB aggregate formation. SAMe prevented the decrease in UPP activity, the increase in LMP2, LMP7, and MECL-1 protein levels and MDB formation induced by DDC. DDC refeeding also induced the TNFalpha and IFNgamma receptors. SAMe prevented the increase in the TNFalpha and IFNgamma receptors, supporting the idea that TNFalpha and IFNgamma were responsible for the up regulation of LMP2, LPM7, and FAT10. These results support the conclusion that MDBs form in FAT10 over-expressing hepatocytes where the up regulation of the immunoproteasome occurs at the expense of the 26S proteasome. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223233      PMCID: PMC3315394          DOI: 10.1016/j.yexmp.2010.03.001

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  42 in total

1.  FAT10, a ubiquitin-independent signal for proteasomal degradation.

Authors:  Mark Steffen Hipp; Birte Kalveram; Shahri Raasi; Marcus Groettrup; Gunter Schmidtke
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

2.  p53 negatively regulates the expression of FAT10, a gene upregulated in various cancers.

Authors:  D W Zhang; K-T Jeang; C G L Lee
Journal:  Oncogene       Date:  2006-04-13       Impact factor: 9.867

3.  Preneoplastic liver cell foci expansion induced by thioacetamide toxicity in drug-primed mice.

Authors:  M Waheed Roomi; Karl Gaal; Qi X Yuan; Barbara A French; Paul Fu; Fawzia Bardag-Gorce; Samuel W French
Journal:  Exp Mol Pathol       Date:  2006-05-24       Impact factor: 3.362

4.  Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits.

Authors:  Antonia Busse; Marianne Kraus; Il-Kang Na; Anika Rietz; Carmen Scheibenbogen; Christoph Driessen; Igor Wolfgang Blau; Eckhard Thiel; Ulrich Keilholz
Journal:  Cancer       Date:  2008-02-01       Impact factor: 6.860

5.  CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation.

Authors:  Fawzia Bardag-Gorce; Barbara A French; Li Nan; Helen Song; Sheila Khanh Nguyen; Holly Yong; Jennifer Dede; Samuel W French
Journal:  Exp Mol Pathol       Date:  2006-10-10       Impact factor: 3.362

Review 6.  New insights into the role of the ubiquitin-proteasome pathway in the regulation of apoptosis.

Authors:  Cui-Hua Liu; Alfred L Goldberg; Xiao-Bo Qiu
Journal:  Chang Gung Med J       Date:  2007 Nov-Dec

7.  S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting the epigenetic memory.

Authors:  Jun Li; Fawzia Bardag-Gorce; Jennifer Dedes; Barbara Alan French; Fataneh Amidi; Joan Oliva; Samuel William French
Journal:  Hepatology       Date:  2008-02       Impact factor: 17.425

8.  E1-L2 activates both ubiquitin and FAT10.

Authors:  Yu-Hsin Chiu; Qinmiao Sun; Zhijian J Chen
Journal:  Mol Cell       Date:  2007-09-21       Impact factor: 17.970

9.  LMP2-specific inhibitors: chemical genetic tools for proteasome biology.

Authors:  Yik Khuan Ho; Paola Bargagna-Mohan; Marie Wehenkel; Royce Mohan; Kyung-Bo Kim
Journal:  Chem Biol       Date:  2007-04

Review 10.  From Mallory to Mallory-Denk bodies: what, how and why?

Authors:  Kurt Zatloukal; Samuel W French; Cornelia Stumptner; Pavel Strnad; Masaru Harada; Diana M Toivola; Monique Cadrin; M Bishr Omary
Journal:  Exp Cell Res       Date:  2007-04-27       Impact factor: 3.905

View more
  16 in total

Review 1.  Emerging roles of immunoproteasomes beyond MHC class I antigen processing.

Authors:  Frédéric Ebstein; Peter-Michael Kloetzel; Elke Krüger; Ulrike Seifert
Journal:  Cell Mol Life Sci       Date:  2012-03-02       Impact factor: 9.261

Review 2.  The role of innate immunity in the pathogenesis of preneoplasia in drug-induced chronic hepatitis based on a mouse model.

Authors:  S W French; F Bardag-Gorce; B A French; J Li; J Oliva
Journal:  Exp Mol Pathol       Date:  2011-07-28       Impact factor: 3.362

3.  Mallory-Denk body pathogenesis revisited.

Authors:  Samuel W French; Fawzia Bardag-Gorce; Jun Li; Barbara A French; Joan Oliva
Journal:  World J Hepatol       Date:  2010-08-27

4.  Mallory-Denk Body (MDB) formation modulates Ufmylation expression epigenetically in alcoholic hepatitis (AH) and non-alcoholic steatohepatitis (NASH).

Authors:  Hui Liu; Ming Gong; Barbara A French; Jun Li; Brittany Tillman; Samuel W French
Journal:  Exp Mol Pathol       Date:  2014-10-05       Impact factor: 3.362

5.  The immunoproteasome in steatohepatitis: its role in Mallory-Denk body formation.

Authors:  B A French; J Oliva; F Bardag-Gorce; S W French
Journal:  Exp Mol Pathol       Date:  2011-01-21       Impact factor: 3.362

6.  Increased expression of FAT10 in colon benign, premalignant and malignant epithelial neoplasms.

Authors:  Xin Qing; Babara A French; Joan Oliva; Samuel W French
Journal:  Exp Mol Pathol       Date:  2010-10-01       Impact factor: 3.362

7.  Oxidative stress, Nrf2 and keratin up-regulation associate with Mallory-Denk body formation in mouse erythropoietic protoporphyria.

Authors:  Amika Singla; David S Moons; Natasha T Snider; Elizabeth R Wagenmaker; V Bernadene Jayasundera; M Bishr Omary
Journal:  Hepatology       Date:  2012-04-25       Impact factor: 17.425

Review 8.  The mechanisms of Mallory-Denk body formation are similar to the formation of aggresomes in Alzheimer's disease and other neurodegenerative disorders.

Authors:  S W French; A S Mendoza; Y Peng
Journal:  Exp Mol Pathol       Date:  2016-04-09       Impact factor: 3.362

9.  FAT10 knock out mice livers fail to develop Mallory-Denk bodies in the DDC mouse model.

Authors:  S W French; B A French; J Oliva; J Li; F Bardag-Gorce; B Tillman; A Canaan
Journal:  Exp Mol Pathol       Date:  2012-09-12       Impact factor: 3.362

10.  Ufmylation and FATylation pathways are downregulated in human alcoholic and nonalcoholic steatohepatitis, and mice fed DDC, where Mallory-Denk bodies (MDBs) form.

Authors:  H Liu; J Li; B Tillman; B A French; S W French
Journal:  Exp Mol Pathol       Date:  2014-06-02       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.